Overview
Aditya Tedjaseputra practices practicing medicine in Clayton, Australia.
Mr. Tedjaseputra is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Leukocytosis, Acute Myeloid Leukemia (AML), Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), Acute Monoblastic Leukemia (AmoL), and Bone Marrow Transplant.
He is actively involved in clinical research, co-authoring 20 peer reviewed articles.
Gender
Locations
Clayton, QLD, Australia
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Aditya Tedjaseputra
Is Aditya Tedjaseputra a top-rated expert for Leukocytosis?
MediFind is an objective health platform that identifies experts based on real-world data. Aditya Tedjaseputra is classified as an Advanced expert for Leukocytosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Aditya Tedjaseputra participate in research or clinical trials?
Yes. Aditya Tedjaseputra has published 20 articles and abstracts on conditions like Leukocytosis. You can view a list of Aditya Tedjaseputra's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Myeloid Leukemia (AML)Mr. Tedjaseputra isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- LeukocytosisMr. Tedjaseputra isAdvanced. Learn about Leukocytosis.
- Experienced
- Acute Monoblastic Leukemia (AmoL)Mr. Tedjaseputra isExperienced. Learn about Acute Monoblastic Leukemia (AmoL).
- Acute Promyelocytic LeukemiaMr. Tedjaseputra isExperienced. Learn about Acute Promyelocytic Leukemia.
- Addison's DiseaseMr. Tedjaseputra isExperienced. Learn about Addison's Disease.
- B-Cell LymphomaMr. Tedjaseputra isExperienced. Learn about B-Cell Lymphoma.
- Bone Marrow TransplantMr. Tedjaseputra isExperienced. Learn about Bone Marrow Transplant.
- Chronic Myelomonocytic Leukemia (CMML)Mr. Tedjaseputra isExperienced. Learn about Chronic Myelomonocytic Leukemia (CMML).
- Disseminated Intravascular CoagulationMr. Tedjaseputra isExperienced. Learn about Disseminated Intravascular Coagulation.
- Hodgkin LymphomaMr. Tedjaseputra isExperienced. Learn about Hodgkin Lymphoma.
- Legionnaire DiseaseMr. Tedjaseputra isExperienced. Learn about Legionnaire Disease.
- LeukemiaMr. Tedjaseputra isExperienced. Learn about Leukemia.
- LymphadenitisMr. Tedjaseputra isExperienced. Learn about Lymphadenitis.
- Marginal Zone Lymphoma (MZL)Mr. Tedjaseputra isExperienced. Learn about Marginal Zone Lymphoma (MZL).
- Membranous NephropathyMr. Tedjaseputra isExperienced. Learn about Membranous Nephropathy.
- MyelitisMr. Tedjaseputra isExperienced. Learn about Myelitis.
- Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
- Non-Hodgkin LymphomaMr. Tedjaseputra isExperienced. Learn about Non-Hodgkin Lymphoma.
- ScrofulaMr. Tedjaseputra isExperienced. Learn about Scrofula.
- Transverse MyelitisMr. Tedjaseputra isExperienced. Learn about Transverse Myelitis.
- Very Long-Chain Acyl-CoA Dehydrogenase (VLCAD) Deficiency